Inventor · disambiguated record
Marvin R. Garovoy
Also filed as: GAROVOY MARVIN · GAROVOY MARVIN R
14 granted patents·6 pending applications·85 citations·filing 1994–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0196US11060128B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2020·Granted Jul 13, 2021·6 cites·28 claims
- 0295US11274332B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 15, 2022·3 cites·26 claims
- 0395US11274331B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 15, 2022·2 cites·28 claims
- 0495US11268128B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 8, 2022·3 cites·17 claims
- 0594US11873525B2Methods of administering 3,4-diaminopridineSERB SA·Filed 2023·Granted Jan 16, 2024·1 cites·29 claims
- 0694US11845977B2Methods of administering 3,4-diaminopridineSERB SA·Filed 2023·Granted Dec 19, 2023·1 cites·24 claims
- 0793US11160869B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Nov 2, 2021·4 cites·25 claims
- 0890US11479593B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Oct 25, 2022·1 cites·30 claims
- 0989US10793893B2Methods of administering 3,4-diaminopyridineGAROVOY MARVIN R·Filed 2012·Granted Oct 6, 2020·9 cites·15 claims
- 1088US6582698B1Treatment methodGENENTECH INC·Filed 2001·Granted Jun 24, 2003·22 cites·8 claims
- 1182US7364734B2Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonistGENENTECH INC·Filed 2005·Granted Apr 29, 2008·2 cites·10 claims
- 1279US2023034700A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2022·Application pending·0 cites
- 1375US2021002693A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2020·Application pending·0 cites
- 1475US2021002694A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2020·Application pending·0 cites
- 1569US2008050364A1Treatment of LFA-1 Associated Disorders with Increasing Doses of LFA-1 AntagonistGENENTECH INC·Filed 2007·Application pending·0 cites
- 1662US2004047859A1Treatment of LFA-1 associated disorders with increasing dosesGENENTECH INC·Filed 2003·Application pending·0 cites
- 1761US2003223988A1Treatment methodGENENTECH INC·Filed 2003·Application pending·0 cites
- 1857US5859226APolynucleotide decoys that inhibit MHC-II expression and uses thereofUNIV CALIFORNIA·Filed 1994·Granted Jan 12, 1999·17 cites·2 claims
- 1952US6410721B1Polynucleotide decoys that inhibit MHC-II expression and uses thereofUNIV CALIFORNIA·Filed 1999·Granted Jun 25, 2002·14 cites·16 claims
- 2037US6652855B1Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonistGENENTECH INC·Filed 2000·Granted Nov 25, 2003·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Marvin R. Garovoy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →